MolecularMatch

📍 Houston, United States🗓 Founded 2014👥 9 employees💰 Last funded Oct 2019
Software Development🌐 molecularmatch.com
Website LinkedIn
MolecularMatch, Inc. is a Houston, Texas-based clinical informatics SaaS company founded in 2014 out of MD Anderson Cancer Center. The company was founded on the vision of using tumor molecular profiling, and outcomes from previously-treated patients, to provide the best personalized treatment for current patients. MolecularMatch delivers personalized, evidence-based therapeutic guidance and clinical trials matched to each patient. Customers include genetic labs, health information systems, biopharma, hospitals, and cancer centers.
5
Total investors
3
Early stage
2
Mid stage
0
Late stage
2014
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2013–2019 · investors recorded per year
20131201412016120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in MolecularMatch?
MolecularMatch has 5 investors on record on gritt.io, including 3 early-stage backers, 2 mid-stage.
When did MolecularMatch last raise funding?
The most recent investment in MolecularMatch recorded on gritt.io was in October 2019.
When was MolecularMatch founded?
MolecularMatch was founded in 2014.
What industry is MolecularMatch in?
MolecularMatch operates in Software Development. Find similar Software Development investors on gritt.io.
Where is MolecularMatch based?
MolecularMatch is headquartered in Houston, United States.